Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

TTI 0102

Next Previous
Drug Profile

TTI 0102

Alternative Names: cysteamine-pantetheine disulfide; cysteamine-R-pantetheine disulfide; TTI-0102

Latest Information Update: 30 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Thiogenesis Therapeutics
  • Class Anti-inflammatories; Antivirals; Small molecules; Thiosulfates
  • Mechanism of Action Antioxidants; Inflammation mediator inhibitors; Metabolism modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II MELAS syndrome
  • No development reported COVID 2019 infections; Traumatic brain injuries

Most Recent Events

  • 25 May 2025 Thiogenesis Therapeutics plans a phase II trial for MELAS syndrome (In adults, In adolescents, In children) in October 2025 (PO)(NCT06990984)
  • 12 May 2025 Phase-II clinical trials in MELAS syndrome in Netherlands, France (PO) (NCT06644534)
  • 28 Mar 2025 No recent reports of development identified for preclinical development in COVID-2019-infections in USA (PO, Powder)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top